CL Biologics

CL Biologics is a leading biologics contract development and manufacturing organization (CDMO) committed to innovation, quality, and enhancing global healthcare outcomes. With a focus on enabling high-quality, affordable biologics worldwide, CL Biologics provides comprehensive CDMO services. These services include world-class facilities, robust process design, digital quality systems, and global compliance, ensuring adherence to cGMP and international regulations.

CL Biologics operates from multiple locations, including its primary address at Baguang International BioValley, Shenzhen, CN. The company also has sites in Beijing, Chengdu, Langfang, and international locations such as 287 Park Ave S, New York, NY 10010, US, and 1069 E Meadow Circle, Palo Alto, California 94303, US, as well as Shanghai, CN. CL Biologics is dedicated to advancing the biotechnology industry through state-of-the-art infrastructure and efficient, innovative processes. The company is currently expanding its capabilities with advanced CDMO plants in Shenzhen and Shanghai, targeting over 700kL capacity by 2026.

CL Biologics' mission is to deliver exceptional value to its partners and contribute to the advancement of global healthcare. To further explore opportunities with CL Biologics and learn more about our services, we invite the company's management to create a customized and exclusive company showcase and product listing on our platform.